Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb (NYSE:BMY) revealed 10 unusual trades.
Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $419,706, and 5 were calls, valued at $156,027.
What's The Price Target?
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $40.0 and $48.0 for Bristol-Myers Squibb, spanning the last three months.
Analyzing Volume & Open Interest
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale trades within a strike price range from $40.0 to $48.0 in the last 30 days.
Bristol-Myers Squibb 30-Day Option Volume & Interest Snapshot
![Options Call Chart](https://www.benzinga.com/files/images/story/2024/1719851462_0.png)
Largest Options Trades Observed:
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|
BMY | PUT | SWEEP | BEARISH | 11/15/24 | $7.6 | $7.45 | $7.55 | $48.00 | $214.4K | 567 | 0 |
BMY | PUT | SWEEP | BEARISH | 08/15/25 | $3.95 | $3.8 | $3.95 | $40.00 | $63.9K | 583 | 0 |
BMY | PUT | SWEEP | BULLISH | 07/12/24 | $2.57 | $2.29 | $2.29 | $43.00 | $57.2K | 34 | 0 |
BMY | PUT | SWEEP | BULLISH | 07/12/24 | $1.48 | $1.43 | $1.43 | $42.00 | $49.9K | 68 | 15 |
BMY | CALL | SWEEP | NEUTRAL | 08/09/24 | $2.36 | $1.09 | $1.87 | $41.00 | $36.2K | 1 | 0 |
About Bristol-Myers Squibb
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.
After a thorough review of the options trading surrounding Bristol-Myers Squibb, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
Where Is Bristol-Myers Squibb Standing Right Now?
- Trading volume stands at 7,489,358, with BMY's price down by -0.35%, positioned at $41.39.
- RSI indicators show the stock to be is currently neutral between overbought and oversold.
- Earnings announcement expected in 25 days.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Bristol-Myers Squibb with Benzinga Pro for real-time alerts.
金融巨頭對百時美施貴寶採取了明顯的看跌舉動。我們對百時美施貴寶(紐約證券交易所代碼:BMY)期權歷史的分析顯示了10筆不尋常的交易。
深入研究細節,我們發現40%的交易者看漲,而50%的交易者表現出看跌趨勢。在我們發現的所有交易中,有5筆是看跌期權,價值爲419,706美元,5筆是看漲期權,價值156,027美元。
目標價格是多少?
在評估了交易量和未平倉合約之後,很明顯,主要市場走勢者將注意力集中在百時美施貴寶過去三個月的價格區間上,價格區間在40.0美元至48.0美元之間。
分析交易量和未平倉合約
交易期權時,查看交易量和未平倉合約是一個強有力的舉動。這些數據可以幫助您跟蹤給定行使價下百時美施貴寶期權的流動性和利息。下面,我們可以觀察過去30天百時美施貴寶所有鯨魚交易的看漲和看跌期權交易量和未平倉合約的變化,其行使價在40.0美元至48.0美元之間。
百時美施貴寶 30 天期權交易量和利息快照
觀察到的最大期權交易:
符號 | 看跌/看漲 | 交易類型 | 情緒 | Exp。日期 | 問 | 出價 | 價格 | 行使價 | 總交易價格 | 未平倉合約 | 音量 |
---|
BMY | 放 | 掃 | 粗魯的 | 11/15/24 | 7.6 美元 | 7.45 美元 | 7.55 美元 | 48.00 美元 | 214.4 萬美元 | 567 | 0 |
BMY | 放 | 掃 | 粗魯的 | 08/15/25 | 3.95 美元 | 3.8 美元 | 3.95 美元 | 40.00 美元 | 63.9 萬美元 | 583 | 0 |
BMY | 放 | 掃 | 看漲 | 07/12/24 | 2.57 美元 | 2.29 美元 | 2.29 美元 | 43.00 美元 | 57.2 萬美元 | 34 | 0 |
BMY | 放 | 掃 | 看漲 | 07/12/24 | 1.48 美元 | 1.43 美元 | 1.43 美元 | 42.00 美元 | 49.9 萬美元 | 68 | 15 |
BMY | 打電話 | 掃 | 中立 | 08/09/24 | 2.36 美元 | 1.09 美元 | 1.87 美元 | 41.00 美元 | 36.2 萬美元 | 1 | 0 |
關於百時美施貴寶
百時美施貴寶發現、開發和銷售用於心血管、癌症和免疫疾病等各種治療領域的藥物。布里斯托爾的重點是免疫腫瘤學,該公司是該領域的藥物開發領導者。布里斯托爾將近70%的總銷售額來自美國,這表明其對美國市場的依賴程度高於大多數同行。
在對百時美施貴寶的期權交易進行了全面審查之後,我們將對該公司進行更詳細的審查。這包括評估其當前的市場狀況和表現。
百時美施貴寶現在的立場在哪裏?
交易量爲7,489,358美元,BMY的價格下跌了-0.35%,爲41.39美元。
RSI指標顯示,該股目前在超買和超賣之間處於中立狀態。
預計將在25天后公佈業績。
交易期權涉及更大的風險,但也提供了更高利潤的潛力。精明的交易者通過持續的教育、戰略貿易調整、利用各種指標以及隨時關注市場動態來降低這些風險。使用 Benzinga Pro 了解百時美施貴寶的最新期權交易,獲取實時提醒。